p.81 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

Circulation. 2025;151:e771–e862. DOI: 10.1161/CIR.0000000000001309 April 1, 2025 e851

ble-blind, placebo-controlled, randomised trial. Lancet. 2014;383:2232– 2237. 8.	 Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–1528. 9.	 Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012–2016. 10.	 Meurin P, Tabet JY, Thabut G, et al. Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial. Ann Intern Med. 2010;152:137–143. 11.	 Meurin P, Lelay-Kubas S, Pierre B, et al. Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial. Heart. 2015;101:1711–1716. 12.	 Bulkley BH, Roberts WC. Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med. 1974;56:244–250. 13.	 Silverman HS, Pfeifer MP. Relation between use of anti-inflammatory

agents and left ventricular free wall rupture during acute myocardial infarction. Am J Cardiol. 1987;59:363–364. 9.4. Management of LV Thrombus After MI 1.	 Camaj A, Fuster V, Giustino G, et al. Left ventricular thrombus following acute myocardial infarction: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79:1010–1022. 2.	 Bulluck H, Chan MHH, Paradies V, et al. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute STsegment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson. 2018;20:72. 3.	 McCarthy CP, Vaduganathan M, McCarthy KJ, et al. Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA Cardiol. 2018;3:642–649. 4.	 Massussi M, Scotti A, Lip GYH, et al. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7:158–167. 5.	 Gellen B, Biere L, Logeart D, et al. Timing of cardiac magnetic resonance imaging impacts on the detection rate of left ventricular thrombus after myocardial infarction. J Am Coll Cardiol Img. 2017;10:1404– 1405. 6.	 Levine GN, McEvoy JW, Fang JC, et al. Management of patients at risk for

and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022;146:e205–e223. 10.1. Cardiac Intensive Care Unit 1.	 Winkler C, Funk M, Schindler DM, et al. Arrhythmias in patients with acute coronary syndrome in the first 24 hours of hospitalization. Heart Lung. 2013;42:422–427. 2.	 Wasfy JH, Kennedy KF, Masoudi FA, et al. Predicting length of stay and the need for postacute care after acute myocardial infarction to improve healthcare efficiency. Circ Cardiovasc Qual Outcomes. 2018;11:e004635. 3.	 Fanaroff AC, Chen AY, Thomas LE, et al. Risk score to predict need

for intensive care in initially hemodynamically stable adults with non- ST-segment-elevation myocardial infarction. J Am Heart Assoc. 2018;7:e008894. 10.2. Management of Anemia in ACS 1.	 Carson JL, Brooks MM, Hebert PC, et al. Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med. 2023;389:2446–2456. 2.	 Vicente-Ibarra N, Marin F, Pernias-Escrig V, et al. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur J Intern Med. 2019;61:48–53. 3.	 Younge JO, Nauta ST, Akkerhuis KM, et al. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. Am J Cardiol. 2012;109:506–510. 4.	 Brener SJ, Mehran R, Dangas GD, et al. Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). Am J Cardiol. 2017;119:1710–1716. 5.	 Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood transfusion

with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med. 2013;173:132– 139. 6 Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion

and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–1562. 7.	 Alexander KP, Chen AY, Wang TY, et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2008;155:1047–1053. 8.	 Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;46:1490–1495. 9.	 Carson JL, Stanworth SJ, Dennis JA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Sys Review. 2021;12:CD002042. 10.	 Carson JL, Stanworth SJ, Guyatt G, et al. Red blood cell transfusion: 2023 AABB international guidelines. JAMA. 2023;330:1892–1902. 11.	 Carson JL, Stanworth SJ, Alexander JH, et al. Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. Am Heart J. 2018;200:96–101. 12.	 Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA 2021;325:552–560. 13.	 Gonzalez-Juanatey JR, Lemesle G, Puymirat E, et al. One-year major cardio-

vascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial. Circulation. 2022;145:486–488. 10.3. Telemetry and Length of Stay 1.	 Piccini JP, White JA, Mehta RH, et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126:41–49. 2.	 Rymer JA, Wegermann ZK, Wang TY, et al. Ventricular arrhythmias after primary percutaneous coronary intervention for STEMI. JAMA Netw Open. 2024;7:e2410288. 3.	 De Luca G, Suryapranata H, van ‘t Hof AW, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004;109:2737–2743. 4.	 Wasfy JH, Kennedy KF, Masoudi FA, et al. Predicting length of stay and the need for postacute care after acute myocardial infarction to improve healthcare efficiency. Circ Cardiovasc Qual Outcomes. 2018;11:e004635. 5.	 Jones DA, Rathod KS, Howard JP, et al. Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction. Heart. 2012;98:1722–1727. 6.	 Melberg T, Jorgensen M, Orn S, et al. Safety and health status following early discharge in patients with acute myocardial infarction treated with primary PCI: a randomized trial. Eur J Prev Cardiol. 2015;22:1427–1434. 7.	 Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998;31:967–972. 8.	 Seto AH, Shroff A, Abu-Fadel M, et al. Length of stay following percutaneous coronary intervention: an expert consensus document update from the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv. 2018;92:717–731. 9.	 Hariri E, Kassas I, Hammoud MA, et al. Same day discharge following nonelective PCI for non-ST elevation acute coronary syndromes. Am Heart J. 2022;246:125–135. 10.	 Pelter MM, Adams MG, Drew BJ. Transient myocardial ischemia is an independent predictor of adverse in-hospital outcomes in patients with acute coronary syndromes treated in the telemetry unit. Heart Lung. 2003;32:71– 78. 11.	 Rahimi K, Watzlawek S, Thiele H, et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006;27:1706–1711. 12.	 Ottander P, Nilsson JB, Jensen SM, Naslund U. Ischemic ST-segment episodes during the initial 24 hours of ST elevation myocardial infarction predict prognosis at 1 and 5 years. J Electrocardiol. 2010;43:224–229. 13.	 Falun N, Nordrehaug JE, Hoff PI, et al. Evaluation of the appropriateness and outcome of in-hospital telemetry monitoring. Am J Cardiol. 2013;112:1219–1223. 14.	 Sandau KE, Funk M, Auerbach A, et al. Update to practice standards for

electrocardiographic monitoring in hospital settings: a scientific statement from the American Heart Association. Circulation. 2017;136:e273–e344.

Downloaded from http://ahajournals.org by on October 7, 2026